Literature DB >> 9806516

Preoperative vs. postoperative radiotherapy in the treatment of soft tissue sarcomas: a matter of presentation.

A Pollack1, G K Zagars, M S Goswitz, R A Pollock, B W Feig, P W Pisters.   

Abstract

PURPOSE: Radiotherapy for soft tissue sarcoma is typically preoperative or postoperative, with advocates of each. In this study, the relationship of the sequencing of radiotherapy and surgery to local control was examined. METHODS AND MATERIALS: The cohort consisted of 453 patients with Grade 2-3 malignant fibrous histiocytoma, synovial sarcoma, or liposarcoma treated from 1965-1992. Retroperitoneal sarcomas were excluded. Median follow-up was 97 months. There were 3 groups of patients that were classified by the treatment administered at our institution: preoperative radiotherapy to a median dose of 50 Gy given before excision at MDACC (Preop; n = 128); postoperative radiotherapy to a median dose of 64 Gy given after excision at MDACC (Postop; n = 165); and radiotherapy to a median dose of 65 Gy without excision at MDACC (RT Alone; n = 160). Those in the RT Alone Group had gross total excision at an outside center prior to referral.
RESULTS: Histological classification, whether locally recurrent at referral, and final MDACC margins were independent determinants of local control in Cox proportional hazards multivariate analysis using the entire cohort. The type of treatment was not significant; however, tumor status at presentation (gross disease vs. excised) affected these findings greatly. Gross disease treated with Preop was controlled locally in 88% at 10 years, as compared to 67% with Postop (p = 0.01). This association was independently significant for patients treated primarily (not for recurrence). In contrast, for those presenting after excision elsewhere, 10-year local control was better with Postop (88% vs. 73%,p = 0.07), particularly for patients treated primarily (91% vs. 72%, p = 0.02 in univariate analysis; p = 0.06 in multivariate analysis). Re-excision at MDACC (Postop) resulted in enhanced 10-year local control over that with RT Alone (88% vs. 75%, p = 0.06), and was confirmed to be an independent predictor in multivariate analysis (p = 0.02).
CONCLUSION: Local control was highest with Preop in patients presenting primarily with gross disease, and with Postop in patients presenting primarily following gross total excision. The data suggest that 50 Gy is inadequate after gross total excision, possibly due to hypoxia in the surgical bed.

Entities:  

Mesh:

Year:  1998        PMID: 9806516     DOI: 10.1016/s0360-3016(98)00277-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  30 in total

Review 1.  [Late complications following neo-/adjuvant radiotherapy and surgery for sarcomas of the extremities or pelvis/retroperitoneum : Preventative measures].

Authors:  C Jentsch; C Hofbauer; S Makocki; E Troost
Journal:  Orthopade       Date:  2020-02       Impact factor: 1.087

2.  Early complications of high-dose-rate brachytherapy in soft tissue sarcoma: a comparison with traditional external-beam radiotherapy.

Authors:  Cynthia L Emory; Corey O Montgomery; Benjamin K Potter; Martin E Keisch; Sheila A Conway
Journal:  Clin Orthop Relat Res       Date:  2012-03       Impact factor: 4.176

3.  Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?

Authors:  Jason Klein; Alex Ghasem; Samuel Huntley; Nathan Donaldson; Martin Keisch; Sheila Conway
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

4.  [Soft tissue sarcoma of the upper extremities. Analysis of factors relevant for prognosis in 160 patients].

Authors:  M Lehnhardt; C Hirche; A Daigeler; O Goertz; A Ring; T Hirsch; D Drücke; J Hauser; H U Steinau
Journal:  Chirurg       Date:  2012-02       Impact factor: 0.955

5.  Body composition predictors of therapy response in patients with primary extremity soft tissue sarcomas.

Authors:  Karen De Amorim Bernstein; Stijn A Bos; Joyce Veld; Santiago A Lozano-Calderon; Martin Torriani; Miriam A Bredella
Journal:  Acta Radiol       Date:  2017-07-26       Impact factor: 1.990

6.  Liposarcoma of the forearm in a man with type 1 neurofibromatosis: a case report.

Authors:  Markus Dietmar Schofer; Mohammed Yousef Abu-Safieh; Jürgen Paletta; Susanne Fuchs-Winkelmann; Bilal Farouk El-Zayat
Journal:  J Med Case Rep       Date:  2009-04-29

7.  Preoperative radiotherapy for adult head and neck soft tissue sarcoma: assessment of wound complication rates and cancer outcome in a prospective series.

Authors:  Brian O'Sullivan; Patrick Gullane; Jonathan Irish; Peter Neligan; Fred Gentili; James Mahoney; Susanna Sellmann; Charles Catton; John Waldron; Dale Brown; Ian Witterick; Jeremy Freeman; Robert Bell
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

8.  Multimodality therapy for metastatic sarcomas confined to the lung.

Authors:  Russell P Gollard; J Francis Turner
Journal:  Oncol Lett       Date:  2012-07-24       Impact factor: 2.967

9.  Primary tumor necrosis predicts distant control in locally advanced soft-tissue sarcomas after preoperative concurrent chemoradiotherapy.

Authors:  Dhara M MacDermed; Luke L Miller; Terrance D Peabody; Michael A Simon; Hue H Luu; Rex C Haydon; Anthony G Montag; Samir D Undevia; Philip P Connell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-07-04       Impact factor: 7.038

Review 10.  [Radiotherapy of soft tissue sarcoma--part of a multidisciplinary strategy].

Authors:  Hildegard Pape; Klaus Orth; Rainer Engers; Christiane Matuschek; Anja Müller; Karl-Axel Hartmann; Peter Arne Gerber; Guido Lammering; Daniel Habermehl; Roland Fenk; Wilfried Budach; Stephan Gripp; Matthias Peiper; Edwin Bölke
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.